Katrin Lorenz
24Patents
4h-index
49Co-inventors
59Inventor score
Filing activity: Jun 18, 2009 → Jul 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9750788B2 | Non-acylated exendin-4 peptide analogues | Chemistry; Metallurgy | 10 | Active |
| US9745360B2 | Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists | Emerging Cross-Sectional Technologies | 5 | Active |
| US9284333B2 | Fused pyrroledicarboxamides and their use as pharmaceuticals | Chemistry; Metallurgy | 5 | Active |
| US9127001B2 | Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them | Chemistry; Metallurgy | 5 | Active |
| US8742116B2 | Cycloalkylamine substituted isoquinolone derivatives | Chemistry; Metallurgy | 3 | Active |
| US9751926B2 | Dual GLP-1/GIP receptor agonists | Chemistry; Metallurgy | 3 | Active |
| US9771406B2 | Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 | Chemistry; Metallurgy | 3 | Active |
| US9789165B2 | Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists | Chemistry; Metallurgy | 3 | Active |
| US9670261B2 | Functionalized exendin-4 derivatives | Emerging Cross-Sectional Technologies | 2 | Active |
| US10519211B2 | Compounds as peptidic GLP1/glucagon/GIP receptor agonists | Chemistry; Metallurgy | 1 | Active |
| US9884860B2 | Fused pyrroledicarboxamides and their use as pharmaceuticals | Chemistry; Metallurgy | 1 | Active |
| US9982029B2 | Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists | Human Necessities | 1 | Active |
| US8524737B2 | Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives | Chemistry; Metallurgy | 0 | Active |
| US8710077B2 | Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives | Human Necessities | 0 | Active |
| US10253079B2 | Functionalized Exendin-4 derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US8399482B2 | 6-substituted isoquinolines and isoquinolinones | Chemistry; Metallurgy | 0 | Active |
| US10538567B2 | Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists | Human Necessities | 0 | Active |
| US9540391B2 | Isomannide derivatives as inhibitors of soluble epoxide hydrolase | Chemistry; Metallurgy | 0 | Active |
| US12054551B2 | FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides | Emerging Cross-Sectional Technologies | 0 | Active |
| US8541449B2 | Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors | Human Necessities | 0 | Active |
| US9776991B2 | Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase | Chemistry; Metallurgy | 0 | Active |
| US10806797B2 | Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate | Human Necessities | 0 | Active |
| US9598410B2 | Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them | Chemistry; Metallurgy | 0 | Active |
| US8772492B2 | Substituted isoquinoline and isoquinolinone derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.